Proteomics

Dataset Information

0

A chemical proteomic analysis of illudin-interacting proteins


ABSTRACT: The illudin natural product family are fungal secondary metabolites with a characteristic spirocyclopropyl-substituted fused 6,5-bicyclic ring system. They have been extensively studied for their cytotoxicity in various tumor cell types and semisynthetic derivatives with improved therapeutic characteristics have progressed into clinical trials. While it is believed that this potent alkylating compound class is mainly acting via DNA modification, little is known about its binding to protein sites in a cellular context. In order to reveal putative protein targets of the illudin family in live cancer cells, we employed a semisynthetic strategy to access a series of illudin-based probes for activity-based protein profiling (ABPP). While the probes largely retained potent cytotoxicity, proteomic profiling studies unravelled multiple protein hits suggesting that illudins exert their mode of action not from addressing a specific protein target but rather from DNA modification and unselective protein binding.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell

SUBMITTER: Nina Bach  

LAB HEAD: Stephan A. Sieber

PROVIDER: PXD014175 | Pride | 2020-01-09

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20150115_PK_ILS1_C1_ILS1H_DMSOL.raw Raw
20150115_PK_ILS1_C2_ILS1H_DMSOL.raw Raw
20150115_PK_ILS1_C3_ILS1H_DMSOL.raw Raw
20150115_PK_ILS1_C4_DMSOH_ILS1L.raw Raw
20150115_PK_ILS1_C5_DMSOH_ILS1L.raw Raw
Items per page:
1 - 5 of 44
altmetric image

Publications

A Chemical Proteomic Analysis of Illudin-Interacting Proteins.

Le Philipp P   Nodwell Matthew B MB   Eirich Jürgen J   Sieber Stephan A SA  

Chemistry (Weinheim an der Bergstrasse, Germany) 20190903 54


The illudin natural product family are fungal secondary metabolites with a characteristic spirocyclopropyl-substituted fused 6,5-bicyclic ring system. They have been extensively studied for their cytotoxicity in various tumor cell types, and semisynthetic derivatives with improved therapeutic characteristics have progressed to clinical trials. Although it is believed that this potent alkylating compound class acts mainly through DNA modification, little is known about its binding to protein site  ...[more]

Similar Datasets

2015-03-06 | E-GEOD-59792 | biostudies-arrayexpress
2011-10-24 | E-GEOD-33151 | biostudies-arrayexpress
2011-10-24 | E-GEOD-33150 | biostudies-arrayexpress
2016-12-05 | PXD004009 | Pride
2011-10-24 | E-GEOD-33149 | biostudies-arrayexpress
2013-12-01 | E-MTAB-1595 | biostudies-arrayexpress
2015-09-03 | E-MTAB-2961 | biostudies-arrayexpress
2017-01-24 | E-MTAB-4607 | biostudies-arrayexpress
2019-07-01 | E-MTAB-7081 | biostudies-arrayexpress
2008-05-20 | E-MEXP-1515 | biostudies-arrayexpress